These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10962155)

  • 1. Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity.
    Pinelli E; Gebhard D; Mommaas AM; van Hoeij M; Langermans JA; Ruitenberg EJ; Rutten VP
    Vet Parasitol; 2000 Oct; 92(3):181-9. PubMed ID: 10962155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.
    Holzmuller P; Cavaleyra M; Moreaux J; Kovacic R; Vincendeau P; Papierok G; Lemesre JL
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):247-57. PubMed ID: 15963823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway.
    Vouldoukis I; Drapier JC; Nüssler AK; Tselentis Y; Da Silva OA; Gentilini M; Mossalayi DM; Monjour L; Dugas B
    Antimicrob Agents Chemother; 1996 Jan; 40(1):253-6. PubMed ID: 8787918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes.
    Panaro MA; Acquafredda A; Lisi S; Lofrumento DD; Mitolo V; Sisto M; Fasanella A; Trotta T; Bertani F; Consenti B; Brandonisio O
    Comp Immunol Microbiol Infect Dis; 2001 Jul; 24(3):187-95. PubMed ID: 11440191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
    Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription of innate immunity genes and cytokine secretion by canine macrophages resistant or susceptible to intracellular survival of Leishmania infantum.
    Turchetti AP; da Costa LF; Romão Ede L; Fujiwara RT; da Paixão TA; Santos RL
    Vet Immunol Immunopathol; 2015 Jan; 163(1-2):67-76. PubMed ID: 25466388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nitric oxide synthase expression in Leishmania-infected dog macrophages.
    Sisto M; Brandonisio O; Panaro MA; Acquafredda A; Leogrande D; Fasanella A; Trotta T; Fumarola L; Mitolo V
    Comp Immunol Microbiol Infect Dis; 2001 Oct; 24(4):247-54. PubMed ID: 11561959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 receptor blockade controls the in vitro infectivity of Leishmania infantum and promotes a Th1 activation in PBMC of dogs with visceral leishmaniasis.
    de Oliveira Cardoso JM; de Brito RCF; Costa AFP; Siqueira Mathias FA; Soares Reis LE; Vieira JFP; de Oliveira Aguiar Soares RD; Reis AB; Roatt BM
    Mol Immunol; 2021 Sep; 137():20-27. PubMed ID: 34182228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages.
    Brandonisio O; Panaro MA; Fumarola I; Sisto M; Leogrande D; Acquafredda A; Spinelli R; Mitolo V
    Clin Exp Med; 2002 Nov; 2(3):125-9. PubMed ID: 12447609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine neutrophils cooperate with macrophages in the early stages of Leishmania infantum in vitro infection.
    Pereira MA; Alexandre-Pires G; Câmara M; Santos M; Martins C; Rodrigues A; Adriana J; Passero LFD; Pereira da Fonseca I; Santos-Gomes G
    Parasite Immunol; 2019 Apr; 41(4):e12617. PubMed ID: 30735568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood mononuclear cell supernatants from asymptomatic dogs immunized and experimentally challenged with Leishmania chagasi can stimulate canine macrophages to reduce infection in vitro.
    Rodrigues CA; Batista LF; Teixeira MC; Pereira AM; Santos PO; de Sá Oliveira GG; de Freitas LA; Veras PS
    Vet Parasitol; 2007 Feb; 143(3-4):197-205. PubMed ID: 17045743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous immune mechanisms in canine leishmaniosis due to Leishmania infantum.
    Papadogiannakis EI; Koutinas AF
    Vet Immunol Immunopathol; 2015 Feb; 163(3-4):94-102. PubMed ID: 25555497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular apoptosis and nitric oxide production in PBMC and spleen from dogs with visceral leishmaniasis.
    de Martini CC; de Andrade JT; de Almeida SKM; Oliveira Silva KL; de Rezende Eugenio F; Dos Santos PSP; de Lima VMF
    Comp Immunol Microbiol Infect Dis; 2018 Apr; 57():1-7. PubMed ID: 30017072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.
    Pinelli E; Gonzalo RM; Boog CJ; Rutten VP; Gebhard D; del Real G; Ruitenberg EJ
    Eur J Immunol; 1995 Jun; 25(6):1594-600. PubMed ID: 7614987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of pro-inflammatory cytokines and iron regulatory protein 2 (IRP2) with Leishmania burden in canine visceral leishmaniasis.
    do Nascimento PR; Martins DR; Monteiro GR; Queiroz PV; Freire-Neto FP; Queiroz JW; Morais Lima AL; Jeronimo SM
    PLoS One; 2013; 8(10):e73873. PubMed ID: 24146743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.